Insmed Incorporated (LON:0JAV)
London · Delayed Price · Currency is GBP · Price in USD 162.56
-2.70 (-1.63%)
At close: Oct 14, 2025
Insmed Market Cap
Insmed has a market cap or net worth of 25.81 billion as of October 16, 2025. Its market cap has increased by 175.71% in one year.
Market Cap
25.81B
Enterprise Value
24.97B
Revenue
290.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
162.56
Market Cap Chart
Since June 1, 2000, Insmed's market cap has increased from 10.71M to 25.81B, an increase of 240,850.27%. That is a compound annual growth rate of 35.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 25.81B | 161.56% |
| Dec 31, 2024 | 9.87B | 183.45% |
| Dec 29, 2023 | 3.48B | 54.93% |
| Dec 30, 2022 | 2.25B | -5.66% |
| Dec 31, 2021 | 2.38B | -4.13% |
| Dec 31, 2020 | 2.48B | 54.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 197.53B |
| GSK plc | 65.86B |
| Haleon | 30.59B |
| Smith & Nephew | 11.11B |
| ConvaTec Group | 4.84B |
| Hikma Pharmaceuticals | 3.98B |
| HUTCHMED (China) | 1.96B |
| Genus | 1.78B |